NEOCODEX - Biobank

Biobank

NeoCodex has built the largest commercial biobank in Europe to provide researchers with unparalleled access to biospecimens representing a wide range of pharmaceutically relevant diseases. Through building a cooperative network of hospitals and physicians throughout the Kingdom of Spain, NeoCodex has established an active association of highly-trained clinical partners, all of whom share a commitment to maintaining the ethical preservation and collection of donated biomaterials. Current collaborating institutions include:

biobank

Hospital 12 de Octubre
Centro Avanzado de Fertilidad de Jerez
Centro Gutenberg, C.R.
CEOGA
Clínica San Cecilio
Hospital Cílnico y Provincial de Barcelona
Complejo Hospitalario Juan Canalejo
Complejo Universitario San Carlos
CREA. Centro Médico de Reproducción Asistida
Hospital de Basurto
Hospital de Cantoblanco
Hospital de Cruces
Hospital de Navarra
Diatros, S.L.
Fundación ACE
Hospital Fundación Alcorcón
Fundación Puigvert I.U.N.A.
Hospital General Universitario de Alicante
Instituto Hispalense de Pediatra
Hospital Ramón y Cajal
Hospital Ruber Internacional
Hospital Santiago Apostol
Hospital Universitario Virgen de Valme
Hospital Universitario La Paz
Hospital Universitario San Juan de Alicante
Hospital Universitario Virgen de las Nieves
Hospital Universitario Virgen del Rocío
Hospital Virgen de la Arrixaca
Complejo Hospitalario Xeral-Calde

Relentless in maintaining an international reputation as an ethical industry leader, all operating procedures supported by NeoCodex fall under the careful continuing review of an outside ethical review board. As such, all patients approached for research donation are carefully screened and approached using a tiered consent. Mindfully written to allow researchers flexibility in the pursuit of commercial research, yet unyielding in the protection of privacy of donating patients, the consent used by NeoCodex respectfully affords participants the option of granting or denying continued access to the collection of follow-up data. Demonstrative of the reliable standing held by NeoCodex within the community, overall participation rates granting continued patient consent remain in excess of 95%.

The NeoCodex biobank samples represent many of the most pharmaceutically relevant diseases, including

biobank_2

Breast Cancer
Laryngeal Cancer
Pancreatic Cancer
Lung Cancer
Thyroid Cancer
Prostate Cancer
Melanoma
Osteoporosis
Diabetes (Type 2)
Colon Cancer
Cardiovascular Risk
Alzheimer's Disease
Asthma / Allergy
Rheumatoid Arthritis
Schizophrenia
Reproductive Diseases

Through a global distribution arrangement created with US-based BioServe BioTechnologies, NeoCodex clients now share access to BioServe's Global Repository, a bank containing over 600,000 human samples (making it the largest commercial repository in the world). Supporting access to biomaterials and meeting the needs of researchers' worldwide, the homogeneous and heterogeneous availability of specimens engaged by the joint collection, now provides representation from a truly worldwide population. Acting to further accommodate researchers requesting data and biomaterials not already banked; NeoCodex remains active in designing prospective collections for biomaterial and patient data, customized to meet the specific needs of researchers seeking acceleration in their clinical and pre-clinical research programs. For more information on how NeoCodex can be of assistance to your specific research needs, please contact: neocodex@neocodex.es